Archive for the ‘Cross Border Issues’ Category
Tuesday, April 1st, 2008
In 1999, between 1.3 and 2.1 billion people did not have access to essential medicines (around 30% of the world’s population), with most of these people being concentrated in Africa and India.[1] In May 2004, after pressure from Canadian civil society groups and Stephen Lewis (the UN Special Envoy on ...
Posted in Pharmaceutical Drugs, Cross Border Issues, Patents, IP | 3 Comments »
Sunday, March 2nd, 2008
Geographical Indicators are terms used to define names that are affixed to predominantly agricultural products (although GIs are also used for other products such as crafts and jewellery, this kind of use is less common) originating from specific geographical regions where these products are grown and manufactured and from which ...
Posted in Cross Border Issues, Trademarks, IP | 1 Comment »
Tuesday, November 13th, 2007
Over the years, judicial and legislative efforts have
dramatically changed the face of US patent law. Traditionally, the United
States prescribed to a patent law regime which was territorial in nature,
meaning that in order for a finding of infringement to be made, the
infraction had to occur wholly within ...
Posted in Cross Border Issues, Patents | 1 Comment »
Tuesday, November 13th, 2007
It is important to appreciate that the principal issue in this case
surrounds the notion of a contract to purchase virtual land. The onus was
on Linden Lab to ensure that their online purchasing system was intact and
not penetrable to unfair usages by purchasers. On the other hand, it ...
Posted in Cross Border Issues, Technology, IP | 1 Comment »
Tuesday, November 13th, 2007
In 2003, the Tufts Center for the Study of Drug Development ("Tufts")
estimated the cost to develop a new drug to be in excess of $850 million.
Today, that figure is likely well into the billions. Tufts also found
that approximately 20% of new drugs that enter clinical testing eventually
receive U.S. marketing approval. ...
Posted in Pharmaceutical Drugs, Cross Border Issues, Patents | 1 Comment »
Tuesday, November 13th, 2007
India’s rejection of Novartis’ claim on drug improvements highlights the flexibility of India’s patent laws. Such flexibility stands in sharp contrast to the World Trade Organization’s efforts to set standards for intellectual property regulation (via TRIPS agreement) and has enabled India to ...
Posted in Pharmaceutical Drugs, Cross Border Issues, Patents | 1 Comment »
Tuesday, November 13th, 2007
In May of 2007 scientists at J. Craig Venter Institute filed a U.S.
patent application on the world's first synthetic living organism
(U.S. Patent application number 20070122826). The patent application
claims include a set of essential genes required to provide the bare
essentials of life as well as a "free-living organism that can grow
and ...
Posted in Cross Border Issues, Patentability, Patents, IP | 1 Comment »
Tuesday, November 13th, 2007
Under traditional legal norms, US patent laws did not extend beyond the
territorial bounds of the union. With a quick one-two punch, however, the
US court of Appeals for the Federal Circuit (CAFC) has expanded the
extraterritorial reach of patent law.
I tend to agree with the statement above (from the Article The Expanding
Reach ...
Posted in Cross Border Issues, IP | 1 Comment »
